Clinical Trials Directory

Trials / Unknown

UnknownNCT00456651

Sleep Apnea-Hypopnea Syndrome and the Pathogenesis of Obesity

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (planned)
Sponsor
Sociedad Española de Neumología y Cirugía Torácica · Academic / Other
Sex
Male
Age
25 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of the study is the following: Patients with sleep apnea-hypopnea syndrome have different pattern in the secretion of hormones. The chronic sleep disorganization that suffer patients with sleep apnea-hypopnea syndrome (SAHS) may affect the central mechanisms that regulate nutritive behavior and energetic balance, causing an alteration in the secretion of hormones that favour the appearance and/or development of obesity.

Detailed description

OBJECTIVES: To compare the plasmatic profiles of different hormones and neuropeptides, related with weight control, metabolism and intake in patients with SAHS as well as in selected control subjects according to weight. DESIGN: Multicenter, prospective and controlled study. 40 patients with SAHS will be included as well as 40 control subjects. METHODS: To all subjects included in the study, the following procedures will be performed: 1. Medical History; 2. Anthropometric variables (height, weight, Body Mass Index; 3. Somnolence evaluation using the Epworth scale; 4. Conventional Polysomnography (PSG); 5. Determination every four hours during a 24 hours period of the levels of leptin adiponectin, resistin, insulin, PCR, etc. 6. Conventional biologic evaluation; 7. Patients will be re-evaluated after three months of treatment with CPAP.

Conditions

Interventions

TypeNameDescription
DEVICECPAP (Continuous Positive Airway Pressure)

Timeline

Start date
2007-02-01
First posted
2007-04-05
Last updated
2007-04-05

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00456651. Inclusion in this directory is not an endorsement.